Skip to content


Latest update
EUROPEAN UNION / EUROPEAN ECONOMIC AREA: Kusum's global manufacturing hubs of Bhiwadi Block II, Rajasthan & SEZ-Pithampur Indore, Madhya Pradesh, India are now EU GMP certified!!!

Young, efficient, and tech-driven, Kusum is a pharmaceutical group of companies headquartered in Delhi, India with its own state-of-the-art manufacturing and R&D facilities spread globally.

4 pharmaceutical drug manufacturing sites, 3 in India (Bhiwadi and SEZ Pithampur) and 1 in Ukraine (Sumy) are equipped with modern equipment from the leading manufacturers of the world.

With the aim to manufacture high quality, affordable, efficient, and safe prescription drugs, and OTC medicines (over-the-counter) for people worldwide, a global team of highly self-motivated, qualified industry specialists work with modern high-precision manufacturing equipment, and with proven world-renowned suppliers of raw materials and pharmaceutical components.

Global Manufacturing

Kusum runs world-class pharmaceutical manufacturing plants at Bhiwadi, Rajasthan and Pithampur, Indore, MP. The pharmaceutical units and systems are designed to meet & exceed all international norms. Its ISO 9001 and ISO 14001 certified plants manufacture pharmaceutical oral solids and topical dosage forms such as tablets, pellets, topical liquids, creams, ointments, shampoo and wax-based suppositories and pessaries. Pharmaceutical packaging facilities are available in the form of blisters, cold forming blisters, sachets, bottles, and tubes. CGMP & Good Documentation Practices resulted in the consistent quality of pharmaceutical products. All core manufacturing areas have dedicated heating, ventilating, and air-conditioning (HVAC) systems with 15 Air Handling Units (AHUs) and High-Efficiency Particulate Air (HEPA) filters to ensure air purity within the production area. 

The pharmaceutical production premises are equipped with PLC-based equipment, which meets CGMP standards. From raw material inputs, packaging material, and in-process checks, strict guidelines are institutionalized to prevent contamination. Access to the production area is restricted, and utmost care is taken to keep the area germ-free. Our obligation to manufacture quality pharmaceutical products ensures that there are no shortcuts.

In-house R&D

Kusum’s pharmaceutical R&D (Research & Development) Facility is equipped with world-class pharmaceutical infrastructure and an industry-leading workforce developing various solid dosage forms along with the capability to handle semi-solid and liquid dosage forms.

We have a specialized team that spearheads pharmaceutical research in the development of market-specific products. In addition, our development team possesses substantial experience and expertise in formulation & development and transfer of pharmaceutical technology. Our key focus areas are Immediate Release, Modified Release & Sustained Release Formulations.


Our drug formulation development team undertakes work on new active substances and generics and further improves effectiveness of existing pharmaceutical products.

All formulations are developed in-house at the state-of-art pharmaceutical formulation R&D center, recognized by the Ministry of Science and Technology, Government of India. The company currently has over 100 dossiers available, with a strong regulatory team to provide dossiers in CTD and ACTD formats to commercialize new formulations.